The personalized lasik surgery market has seen considerable growth due to a variety of factors.
• In the past few years, the market size for personalized lasik surgery has seen a robust increase. The market is projected to rise from $2.63 billion in 2024 to $2.82 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.2%.
This growth during the historic period is resultant of factors such as increased public awareness pertaining to Lasik surgery, a surge in cases of refractive errors, expansion of centers devoted to refractive surgery, betterment in patient safety and results, along with support from government regulations.
The personalized lasik surgery market is expected to maintain its strong growth trajectory in upcoming years.
• Strong expansion is predicted for the personalized lasik surgery market in the coming years. The market is projected to reach $3.69 billion by 2029, with a compound annual growth rate (CAGR) of 6.9%.
The anticipated growth in this period is due to factors like the increasing elderly population, an upsurge in vision disorders, rising knowledge and education about the procedure, developing healthcare infrastructure, and the expansion of medical tourism. Advancements in LASIK platforms, the employment of laser-aided systems, technological evolutions, improved patient experiences, and tailored treatment options are the key trends that will dominate this forecast period.
The escalating issue of eye-related diseases is predicted to fuel the advancement of the personalized LASIK surgery market. These diseases, such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy, impact both the eyes and vision. The increase in such conditions can be attributed to factors including an aging population, a higher occurrence of chronic illnesses like diabetes, and lifestyle aspects like extended screen use, all of which result in a greater likelihood of developing vision problems. Personalized LASIK surgery is an approach to these problems as it offers bespoke vision correction solutions, improving the precision, efficiency, and patient results in cases of myopia and astigmatism. For example, Eurostat, a government agency based in Luxembourg, reported in 2022 that cataract surgeries, which involve the removal of the eye's natural lens, were carried out 4.73 million times throughout EU nations in September 2024. Consequently, the escalating prevalence of ophthalmic diseases is anticipated to catalyze the personalized LASIK surgery market's growth.
The personalized lasik surgerymarket covered in this report is segmented –
1) By Type: Topography Guided LASIK, Wavefront Guided LASIK, Wavefront Optimized LASIK
2) By Indications: Myopia, Hypermetropia, Presbyopia, Other Indications
3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Topography Guided LASIK: Corneal Topography Mapping, Customized Treatment Plans
2) By Wavefront Guided LASIK: Aberrometry Analysis, Customized Wavefront Maps
3) By Wavefront Optimized LASIK: Standardized Treatment Protocols, Preserving Natural Aberrations
Key corporations in the personalized LASIK surgery market are focusing their efforts on the adoption of more intelligent LASIK systems, such as laser-assisted platforms, to enhance precision, better patient outcomes, and simplify surgical processes. These laser-assisted systems entail the use of cutting-edge technology in eye surgeries to precisely alter the cornea's shape for vision adjustment, providing greater accuracy and customization compared to traditional techniques. For example, Bausch + Lomb Corporation, an eye health business based in Canada, acquired FDA approval for its TENEO Excimer Laser Platform for LASIK surgery to rectify myopia and myopic astigmatism in January 2024. The platform boasts a sophisticated eye-tracker that operates at 1740 Hz, triple the speed of the laser's repetition, and a 500 Hz laser with the fastest ablation time amongst excimer lasers in the U.S., delivering roughly 1.2 seconds per diopter.
Major companies operating in the personalized LASIK surgery market are:
• Abbott Laboratories
• Stryker Corporation
• Carl Zeiss AG
• Alcon Inc.
• Bausch Health Companies Inc.
• Medtronic plc
• Santen Pharmaceutical Co. Ltd.
• Topcon Corporation
• Johnson & Johnson Vision Care Inc.
• STAAR Surgical Company
• Optical Express Ltd.
• The LASIK Vision Institute LLC
• LASIK MD Inc.
• Centre For Sight Limited
• Technolas Perfect Vision GmbH
• Optegra Eye Health Care Ltd.
• IntraLase LLC
• SCHWIND eye-tech-solutions GmbH
• Optimax Clinics Limited
• NIDEK Co. Ltd.
• Shanghai New Eyes Medical Inc.
• Ziemer Ophthalmic Systems AG
• LaserSight Technologies Inc.
• Presbia PLC
North America was the largest region in the personalized LASIK surgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized LASIK surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.